Sort   by:  
 Page size 
UnknownSelumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.
Not available
S-EPMC5815037 | biostudies-literature
UnknownRandomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer.
Not available
S-EPMC4017965 | biostudies-literature
UnknownAfatinib in EGFR TKI-Naive Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.
Not available
S-EPMC8298067 | biostudies-literature
UnknownOsimertinib plus platinum-pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study.
Not available
S-EPMC8453202 | biostudies-literature
UnknownDurvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN.
Not available
S-EPMC9161394 | biostudies-literature
UnknownDurvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Not available
S-EPMC10870117 | biostudies-literature
UnknownPhase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.
Not available
S-EPMC11795518 | biostudies-literature
UnknownOsimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Not available
S-EPMC6762027 | biostudies-literature
Sort   by:  
 Page size